OPULENT PHARMA IMPURITY STOCK LIST - B
OPULENT PHARMA IMPURITY STOCK LIST
UPDATED OCTOBER 2019
|
||
Ground Floor, 8, Aagam Heritage,
Opposite Someshwara Square, Vesu, Surat, Gujarat-395007
Contact: +91-9106692785 E-mail: info@opulentpharma.com www.opulentpharma.com |
||
If you cannot find your product of interest……..we
offer custom synthesis support
Kindly share your inquiry by mail to info@opulentpharma.com or Call/Message/Watsapp to +91-9106692785. We shall reverst with competitive price and lead time for the same. |
||
|
||
A-Z
|
IMPURITY STOCK LIST
|
CAS NUMBER
|
B
|
Product: BACLOFEN IMPURITIES
|
|
B
|
Baclofen EP Impurity A
|
22518-27-0
|
B
|
Baclofen EP Impurity B
|
1141-23-7
|
B
|
Baclofen Impurity 1
|
35271-74-0
|
B
|
Chlorophenylglutaric acid anhydride
|
53911-68-5
|
B
|
4-(4-Chlorophenyl)-2,6-piperidinedione
|
84803-46-3
|
B
|
2-(4-Chlorophenyl)-4-hydroxy-4-methyl-6-oxo-1,3-Cyclohexanedicarboxylic
Acid Diethyl Ester
|
294194-13-1
|
B
|
Butyl 4-amino-3-(p-chlorophenyl)butyrate
|
|
B
|
4-Amino-3-(3,4-dichlorophenyl)butyric acid
|
|
B
|
Dibaclofen Urea
(N,N-Di[3-carboxy-2-(4-chlorophenyl)-propyl]urea)
|
|
B
|
Dibaclofen Urea Mono Lactum
(3-(p-Chlorophenyl)-4-{[4-(p-chlorophenyl)-2-oxo-1-pyrrolidinyl]carbonylamino}butyric
acid)
|
|
B
|
Product: BALSALAZIDE IMPURITIES
|
|
B
|
Balsalazide Related Compound A
|
1242567-07-2
1398634-47-3 |
B
|
Balsalazide Related Compound B
|
1242567-09-4
|
B
|
Balsalazide Isopropyl Ester
|
1346606-13-0
|
B
|
Balsalazide Aminobenzoyl Impurity
|
7377-08-4
|
B
|
Product: BAZEDOXIFENE IMPURITIES
|
|
B
|
Bazedoxifene N-Oxide
|
1174289-22-5
|
B
|
Product: BECLOMETASONE IMPURITIES
|
|
B
|
Beclometasone Dipropionate EP Impurity R
|
981-34-0
|
B
|
Beclometasone Dipropionate EP Impurity V (Betamethasone
9,11-Epoxide 21-Propionate)
|
205105-83-5
|
B
|
Product: BENAZEPRIL IMPURITIES
|
|
B
|
Benazepril EP Impurity C/ Benazepril Related Compund C
(Benazeprilat)
|
86541-78-8
|
B
|
Benazepril EP Impurity D/ Benazepril Related Compund D
|
|
B
|
Benazepril EP Impurity E/ Benazepril Related Compund E
|
88372-47-8
2013-07-05 |
B
|
Benazepril EP Impurity F/ Benazepril Related Compund F
|
109010-60-8
|
B
|
Benazepril EP Impurity G/ Benazepril Related Compund G
(Benazepril Ethyl Ester)
|
103129-58-4
|
B
|
Product: BENDAMUSTINE IMPURITIES
|
|
B
|
Bendamustine Related Compound A (Bendamustine Dihydroxy
Impurity)
|
109882-30-6
|
B
|
Bendamustine Related Compound E (Bendamustine Monohydroxy Acid
Impurity)
|
109882-27-1
|
B
|
Bendamustine Related Compound G (Bendamustine Impurity D/
Bendamustine Thiazine Impurity)
|
191939-34-1
|
B
|
Bendamustine Related Compound H (Bendamustine Trichloroethyl
Dimer Impurity)
|
1228551-91-4
|
B
|
Bendamustine Methyl Ester
|
109882-25-9
|
B
|
Bendamustine Hydrochloride - In house impurity
|
109882-31-7
|
B
|
Bendamustine Dideschloroethyl Acid Impurity
|
914626-62-3
|
B
|
Bendamustine Isopropyl Ester
|
1313020-25-5
|
B
|
Deschloroethyl Bendamustine
|
1219709-86-0
1797881-48-1 |
B
|
Bendamustine Deschloro Dimer Impurity/ Bendamustine
Trihydroxyethyl Dimer Impurity
|
1391052-61-1
|
B
|
N1-Methylbenzene-1,2,4-triamine hydrochloride
|
60651-29-8
|
B
|
Bendamustine Dideschloroethyl Ethyl Ester
|
3543-73-5
|
B
|
Product: BENOXACOR IMPURITIES
|
|
B
|
2,2-dichloro-N-[2-(hydroxypropoxy)phenyl]acetamide
|
|
B
|
Product: BENZOTHIADIAZINE IMPURITIES
|
|
B
|
Benzothiadiazine Related Compound A (Hydrochlorothiazide EP
Impurity B/ Hydrochlorothiazide Related Compound A/ Salamide/ Altizide EP
Impurity A)
|
121-30-2
|
B
|
Product: BENZYDAMINE IMPURITIES
|
|
B
|
Benzydamine
EP Impurity C
|
2215-63-6
|
B
|
Product: BESIFLOXACIN IMPURITIES
|
|
B
|
Besifloxacin Impurity B
|
101987-89-7
|
B
|
Besifloxacin Impurity G/ (R)-3-Amino-hexahydroazepine/
Besifloxacin (R)-Azepan-3-Amine Impurity
|
124932-43-0
|
B
|
Besifloxacin (3S)-Isomer
|
141388-77-4
|
B
|
(3R)-3-Aminoazepane-1-carboxylic Acid tert-Butyl Ester
|
1032684-85-7
|
B
|
Boc-L-serine
|
3262-72-4
|
B
|
Product: BETAHISTINE IMPURITIES
|
|
B
|
Betahistine EP Impurity A
|
100-69-6
|
B
|
Betahistine EP Impurity B
|
103-74-2
|
B
|
Betahistine EP Impurity C
|
2095467-43-7
5452-87-9 |
B
|
2-Pyridyl acetic Acid
|
13115-43-0
|
B
|
Product: BETAMETHASONE IMPURITIES
|
|
B
|
Betamethasone Dipropionate EP Impurity A
|
378-44-9
|
B
|
Betamethasone Dipropionate Impurity B (EP)/ Clobetasol
Propionate Impurity-A (EP) (Betamethasone 17-Propionate)
|
5534-13-4
|
B
|
Betamethasone Dipropionate Impurity C (EP)/ Clobetasol
Propionate Impurity-K (EP) (Betamethasone 21-Propionate)
|
75883-07-7
|
B
|
Betamethasone Dipropionate EP Impurity G (Betamethasone
Tripropionate)
|
1186048-33-8
|
B
|
Betamethasone Impurity B (EP)/ Clobetasol Propionate Impurity-G (EP)
|
25122-41-2
|
B
|
Betamethasone Acetate EP Impurity B (Dexamethasone EP Impurity
G/ 21-O-Acetyl Dexamethasone)
|
1177-87-3
|
B
|
Betamethasone 9,11-Epoxide 21-Propionate (Beclometasone
Dipropionate EP Impurity V)
|
205105-83-5
|
B
|
Betamethasone Valerate
|
2152-44-5
|
B
|
Product: BETAXOLOL IMPURITIES
|
|
B
|
Betaxolol EP Impurity A
|
67193-95-7
464877-45-0 |
B
|
Product: BEZAFIBRATE IMPURITIES
|
|
B
|
Bezafibrate EP Impurity B (Acemetacin EP Impurity A/
Indomethacin EP Impurity A/ Indomethacin Related Compound B)
|
74-11-3
|
B
|
Product: BICALUTAMIDE IMPURITIES
|
|
B
|
Bicalutamide EP Impurity A (Desfluoro Bicalutamide)
|
90357-05-4
|
B
|
Bicalutamide EP Impurity B (Bicalutamide 2-Fluoro Isomer)
|
1159977-36-2
|
B
|
Bicalutamide EP Impurity C (Bicalutamide Deshydroxy Impurity)
|
906008-94-4
|
B
|
Bicalutamide EP Impurity D
|
654-70-6
|
B
|
Bicalutamide EP Impurity H
|
|
B
|
Bicalutamide EP Impurity J (Bicalutamide Sulfide)
|
90356-78-8
|
B
|
Bicalutamide EP Impurity K & L
|
|
B
|
Bicalutamide Related Compound B (Bicalutamide 3-Fluoro Isomer)
|
1166228-30-3
|
B
|
Product: BIFONAZOLE IMPURITIES
|
|
B
|
Bifonazole EP Impurity C (Clotrimazole EP Impurity D/ Enalapril
EP Impurity I/ Ondansetron EP Impurity E/ Imidazole)
|
288-32-4
|
B
|
Product: BIMATOPROST IMPURITIES
|
|
B
|
Bimatoprost Acid
|
38344-08-0
|
B
|
15-Keto Bimatoprost
|
1163135-96-3
|
B
|
Bimatoprost Acid Methyl Ester
|
38315-47-8
|
B
|
5,6-Trans Bimatoprost
|
1163135-95-2
|
B
|
15-epi Bimatoprost
|
1163135-92-9
|
B
|
Bimatoprost
isopropyl ester
|
130273-87-9
|
B
|
Product: BISACODYL IMPURITIES
|
|
B
|
Bisacodyl EP Impurity A/ Bisacodyl Related Compound A
|
603-41-8
|
B
|
Bisacodyl EP Impurity C/ Bisacodyl Related Compound C
|
72901-16-7
|
B
|
Product: BISOPROLOL IMPURITIES
|
|
B
|
Bisoprolol EP Impurity A (Des(isopropoxyethyl) Bisoprolol)
|
62572-93-4
|
B
|
Bisoprolol EP Impurity B (Bisoprolol Propyl Analog)
|
1447715-44-7
|
B
|
Bisoprolol EP Impurity G
|
1215342-36-1
|
B
|
Bisoprolol EP Impurity K (Bisoprolol Ester Impurity)
|
1346603-26-6
864544-37-6 |
B
|
Bisoprolol EP Impurity L
|
29122-74-5
|
B
|
Bisoprolol EP Impurity M
|
177034-57-0
|
B
|
Bisoprolol EP Impurity N
|
1346601-75-9
|
B
|
Bisoprolol EP Impurity Q
|
1346604-00-9
|
B
|
Bisoprolol EP Impurity S (4-Hydroxybenzaldehyde)
|
123-08-0
|
B
|
Bisoprolol Carboxylic Acid Impurity
|
72570-70-8
|
B
|
Bisoprolol Dimer
|
|
B
|
N-Formyl Bisoprolol
|
1447715-45-8
|
B
|
Bisoprolol Impurity 1
|
1346603-05-1
|
B
|
4-(2,3-Epoxypropoxy)benzaldehyde
|
14697-49-5
|
B
|
1,1'-[Methylenebis(4,1-phenyleneoxy)]bis[3-[(1-methylethyl)amino]-2-propanol
|
1225195-70-9
|
B
|
Product: BLONANSERIN IMPURITIES
|
|
B
|
Desfluoro Blonanserin
|
132810-75-4
|
B
|
Chloro Blonanserin
|
|
B
|
Methoxy Blonanserin
|
|
B
|
N-Methyl Blonanserin
|
|
B
|
Desethyl Blonanserin
|
132811-84-8
|
B
|
Blonanserin Impurity
|
3672-47-7
|
B
|
Blonanserin Impurity
|
4640-66-8
|
B
|
Blonanserin Impurity
|
614-16-4
|
B
|
Product: BORTEZOMIB IMPURITIES
|
|
B
|
Bortezomib Related Compound A/ Bortezomib Impurity D (Bortezomib
R,R-Isomer Impurity)
|
1132709-15-9
|
B
|
Bortezomib Related Compund B/ Bortezomib Amide Analog
|
289472-80-6
|
B
|
Bortezomib Related Compund D/ Bortezomib Acid Analog
|
114457-94-2
|
B
|
Bortezomib Related Compound G (Bortezomib S,S-Isomer Impurity)
|
1132709-14-8
|
B
|
Bortezomib Related Compund I/ (S,R)-Bortezomib Hydroxyisopentyl
Amide Analog (Bortezomib Hydroxy S,R-Isomer Impurity)
|
289472-78-2
|
B
|
Bortezomib Related Compund J/ (S,S)-Bortezomib Hydroxyisopentyl
Amide Analog (Bortezomib Hydroxy S,S-Isomer Impurity)
|
289472-81-7
|
B
|
Bortezomib Impurity F/ Bortezomib Acid Methyl Ester
|
73058-37-4
|
B
|
Bortezomib Impurity H
|
1446194-56-4
|
B
|
Bortezomib S,R-Isomer Impurity
|
1132709-16-0
|
B
|
Bortezomib Amino R Isomer
|
179324-87-9
|
B
|
Bortezomib Pinanediol Impurity
|
205393-22-2
|
B
|
Product: BOSENTAN IMPURITIES
|
|
B
|
Bosentan Related Compound A
|
150727-06-3
|
B
|
Bosentan Related Compound B (O-Deshydroxyethyl Bosentan)
|
174227-14-6
|
B
|
Bosentan Related Compound C
|
1097263-60-9
|
B
|
Bosentan Related Compound D
|
150728-13-5
|
B
|
Bosentan Related Compound E
|
6292-59-7
|
B
|
4-Chloro-6-[2-(1,1-dimethylethoxy)ethoxy]-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
|
1177447-87-8
|
B
|
Product: BREXPIPRAZOLE IMPURITIES
|
|
B
|
Brexpiprazole 5-1H-Quinolin-2-one
|
2116542-20-0
|
B
|
Brexpiprazole (3,4)-Dihydro-2(1H)-quinolinone
|
913612-07-4
|
B
|
Brexpiprazole N-Oxide
|
1191900-58-9
|
B
|
Brexpiprazole Sulfoxide
|
1191900-51-2
|
B
|
7-(4-bromobutoxy)quinolin-2(1H)-one/ Aripiprazole Bromo Impurity
|
203395-59-9
|
B
|
7-(4-Hydroxybutoxy)-2(1H)-quinolinone
|
1886188-97-1
|
B
|
N-(3-hydroxyphenyl)cinnamamide
|
616227-75-9
|
B
|
N-(3-methoxyphenyl)cinnamamide
|
15116-41-3
|
B
|
5-hydroxyquinolin-2(1H)-one
|
31570-97-5
|
B
|
1,4-Bis(benzo[b]thien-4-yl)piperazine
|
1420987-86-5
|
B
|
7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)quinolin-2(1H)-one
|
2094559-58-5
|
B
|
Piperazine-1-(4-benzofuranyl) hydrochloride
|
105684-85-3
|
B
|
7-(4-(4-(benzofuran-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one
|
|
B
|
1-([2,4'-bibenzo[b]thiophen]-4-yl)piperazine
|
2126178-13-8
|
B
|
7-(4-(4-([2,4'-bibenzo[b]thiophen]-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one
|
|
B
|
7,7'-[(1,4-Butanediyl)bis(oxy)]bis-2(1H)quinolinone
|
2116542-19-7
|
B
|
1-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butyl)-7-hydroxyquinolin-2(1H)-one
|
|
B
|
1-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butyl)-7-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butoxy)quinolin-2(1H)-one
|
|
B
|
7-(4-(4-(2,3-dihydro-[2,4'-bibenzo[b]thiophen]-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one
|
|
B
|
7-(4-Chlorobutoxy)-1-(4-chlorobutyl)quinolin-2-one
|
2059954-32-2
|
B
|
1,4-bis(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butane
|
|
B
|
1-(Benzo[b]thiophen-4-yl)-4-(4-((2-oxo-l,2-dihydroquinolin-7-yl)oxy)butyl)
piperazine 1,4-dioxide
|
|
B
|
1-(2,3-dihydro-[2,4'-bibenzo[b]thiophen]-4-yl)piperazine
|
1420987-85-4
|
B
|
1-(benzo[b]thiophen-4-yl)-4-(4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butyl)piperazine
1,4-dioxide
|
|
B
|
1-(benzo[b]thiophen-4-yl)piperazine
|
846038-18-4
|
B
|
7-(4-(piperzin-1-yl)butoxy)quinolin-2(1H)-one
|
1849603-58-2
|
B
|
7,7'-((piperazine-1,4-diylbis(butane-4,1-diyl))bis(oxy))bis(quinolin-2(1H)-one)
|
2220149-92-6
|
B
|
4-Bromo benzo[b]thiophene
|
5118-13-8
|
B
|
7-(4-chloro butoxy)-1H-quinolin-2-one
|
913613-82-8
|
B
|
Benzo thiophene
|
95-15-8
|
B
|
Product: BRIMONIDINE IMPURITIES
|
|
B
|
Brimonidine EP Impurity A (Desbromo Brimonidine)
|
91147-43-2
|
B
|
Brimonidine EP Impurity B/ Brimonidine Related Compound A
|
50358-63-9
|
B
|
Brimonidine EP Impurity C (Quinoxalin-6-amine)
|
6298-37-9
|
B
|
Product: BRINZOLAMIDE IMPURITIES
|
|
B
|
Desmethyl Brinzolamide
|
186377-56-0
|
B
|
Brinzolamide methanesulfonyl Impurity
|
|
B
|
Product: BRIVUDINE IMPURITIES
|
|
B
|
Beta-(Z)-Brivudine (β-(Z)-Brivudine)
|
|
B
|
Product: BROMFENAC IMPURITIES
|
|
B
|
Bromfenac Lactam
|
91713-91-6
|
B
|
2-Amino-3-(4-bromobenzoyl)benzoic Acid
|
241496-82-2
|
B
|
7-(4-Bromobenzoyl)-1H-indole-2,3-dione
|
241825-88-7
|
B
|
2-Amino-3-(4-bromobenzoyl)phenyloxoacetic Acid
|
1391052-54-2
241825-87-6 |
B
|
2-Amino-3-benzoyl-α-oxo-benzeneacetic Acid
|
126849-31-8
|
B
|
7-Benzoylindoline-2,3-dione
|
70803-94-0
|
B
|
Product: BROMHEXINE IMPURITIES
|
|
B
|
Bromhexine EP Impurity A (Ambroxol EP Impurity A)
|
50739-76-9
|
B
|
Bromhexine EP Impurity B (Ambroxol EP Impurity E)
|
50910-55-9
|
B
|
Product: BRONOPOL IMPURITIES
|
|
B
|
Tris(hydroxymethyl)nitromethane
|
126-11-4
|
B
|
2-Methyl-2-nitro-1,3-propanediol
|
77-49-6
|
B
|
Product: BUDESONIDE
IMPURITIES
|
|
B
|
Budesonide EP Impurity-A
|
13951-70-7
|
B
|
Budesonide EP Impurity-B (Budesonide Acetylaldehyde Acetal)
|
1040085-98-0
|
B
|
Budesonide EP Impurity-D (Budesonide Aldehyde Impurity)
|
85234-63-5
|
B
|
Budesonide EP Impurity-E/ Budesonide Related Compund
E(14,15-Dehydro Budesonide)
|
131918-64-4
|
B
|
Budesonide EP Impurity-F (Desonide)
|
638-94-8
|
B
|
Budesonide EP Impurity-I (16α-Butyloxy Prednisolone)
|
113930-13-5
|
B
|
Budesonide EP Impurity-K (Budesonide 21-Acetate)
|
51333-05-2
|
B
|
Budesonide EP Impurity-L/ Budesonide Related Compund L(11-Keto
Budesonide)
|
216453-74-6
|
B
|
Product: BUMETANIDE IMPURITIES
|
|
B
|
Bumetanide EP Impurity A/ Bumetanide Related Compound B
|
28328-53-2
|
B
|
Bumetanide EP Impurity B/ Bumetanide Related Compound A
(Desbutyl Bumetanide)
|
28328-54-3
|
B
|
Bumetanide EP Impurity C (Bumetanide Butyl Ester)
|
32643-00-8
|
B
|
Bumetanide EP Impurity D
|
153012-65-8
|
B
|
Bumetanide Impurity 1
|
22892-96-2
|
B
|
Bumetanide Impurity
|
67155-14-0
|
B
|
Bumetanide Impurity
|
56106-57-1
|
B
|
N-Desbutyl-N-propyl Bumetanide
|
28395-28-0
|
B
|
Product: BUPIVACAINE IMPURITIES
|
|
B
|
Bupivacaine EP Impurity A (Mepivacaine EP Impurity C)
|
39627-98-0
|
B
|
Bupivacaine EP Impurity B/ Bupivacaine Related Compound B
(Mepivacaine EP Impurity B/ N-Desbutyl Bupivacaine)
|
15883-20-2
65797-42-4 |
B
|
Bupivacaine EP Impurity E/ Bupivacaine Related Compound A
|
1330172-81-0
|
B
|
Bupivacaine EP Impurity F (Lidocaine EP Impurity A/ Lidocaine
Related Compound A/ Ropivacaine EP Impurity H/ Ropivacaine Related Compound
A/ Mepivacaine EP Impurity A)
|
87-62-7
21436-98-6 |
B
|
1-(2,6-Dimethylphenyl)azepan-2-one (Cyclised Impurity)
|
|
B
|
4-Hexylbenzene-1,3-diol
|
136-77-6
|
B
|
1-(2,4-Dihydroxyphenyl)hexan-1-one
|
3144-54-5
|
B
|
4-pentylbenzene-1,3-diol
|
533-24-4
|
B
|
1-(2,4-dihydroxyphenyl)pentan-1-one
|
15116-13-9
|
B
|
Product: BUPROPION IMPURITIES
|
|
B
|
Bupropion Related Compound A
|
1049718-72-0
|
B
|
Bupropion Related Compound B
|
1049718-43-5
|
B
|
Bupropion Related Compound C
|
152943-33-4
|
B
|
Bupropion Related Compound D (Deschloro Bupropion)
|
63199-74-6
34509-36-9 |
B
|
Bupropion Related Compound E
|
10557-17-2
|
B
|
Bupropion Related Compound F
|
857233-13-7
|
B
|
(3S,5R,6R)-Bupropion Impurity
|
2133460-43-0
|
B
|
Bupropion Des-t-tbutylamine Impurity (3’-Chloropropiophenone)
|
936-59-4
|
B
|
Bupropion 2-Bromo Impurity
|
34911-51-8
|
B
|
Bupropion Amino Impurity
|
119802-69-6
|
B
|
Bupropion 3,4-Dichloro Impurity
|
1193779-34-8
|
B
|
Bupropion Des-t-Butylamino Impurity
|
34841-35-5
|
B
|
Bupropion 2-Chloro Analog
|
1049718-57-1
|
B
|
Bupropion 3,5-Dichloro Impurity
|
1193779-48-4
|
B
|
Product: BUSPIRONE IMPURITIES
|
|
B
|
Buspirone EP Impurity A/ Buspirone Related Compound A
|
20980-22-7
|
B
|
Buspirone EP Impurity B
|
81461-73-6
|
B
|
Buspirone EP Impurity C/ Buspirone Bispyrimidinylpiperazinyl
Butane Impurity
|
257877-45-5
|
B
|
Buspirone EP Impurity D/ Buspirone
Bispyrimidinylpiperazinylbutyl Ether Impurity
|
|
B
|
Buspirone EP Impurity E/ Buspirone Open Ring Impurity
|
257877-46-6
|
B
|
Buspirone EP Impurity F/ Buspirone Open-Ring Dimer Impurity
|
|
B
|
Buspirone EP Impurity G/ Buspirone Related Compound G
|
84746-24-7
|
B
|
Buspirone EP Impurity H/ Buspirone Diester Dimer
|
|
B
|
Buspirone EP Impurity I/ 5-Chloro Buspirone
|
|
B
|
Buspirone EP Impurity J/ Buspirone Open Ring Spirodimer Impurity
|
|
B
|
Buspirone EP Impurity K/ Buspirone Related Compound K
|
1075-89-4
|
B
|
Buspirone EP Impurity L/ Buspirone Related Compund L
|
21098-11-3
|
B
|
Buspirone EP Impurity M/ Buspirone Bromobutyl Impurity
|
80827-62-9
|
B
|
Buspirone EP Impurity N/ Buspirone Related Compund N
|
257877-44-4
|
B
|
Buspirone N-Oxide
|
220747-81-9
|
B
|
Buspirone 5-Hydroxy Metabolite
|
105496-33-1
|
B
|
Buspirone 6-Hydroxy Metabolite
|
125481-61-0
|
B
|
Product: BUSULFAN IMPURITIES
|
|
B
|
Busulfan Methylsulfinyloxy Analog
|
106-48-9
|
B
|
Product: BUTANILICAINE IMPURITIES
|
|
B
|
2,2'-Dichloro-6'-methylacetanilide
|
6307-67-1
|
Comments
Post a Comment